 |
PDBsum entry 3c6u
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The design and synthesis of diaryl ether second generation HIV-1 non-Nucleoside reverse transcriptase inhibitors (nnrtis) with enhanced potency versus key clinical mutations.
|
 |
|
Authors
|
 |
T.J.Tucker,
S.Saggar,
J.T.Sisko,
R.M.Tynebor,
T.M.Williams,
P.J.Felock,
J.A.Flynn,
M.T.Lai,
Y.Liang,
G.Mcgaughey,
M.Liu,
M.Miller,
G.Moyer,
V.Munshi,
R.Perlow-Poehnelt,
S.Prasad,
R.Sanchez,
M.Torrent,
J.P.Vacca,
B.L.Wan,
Y.Yan.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2008,
18,
2959-2966.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Using a combination of traditional Medicinal Chemistry/SAR analysis,
crystallography, and molecular modeling, we have designed and synthesized a
series of novel, highly potent NNRTIs that possess broad antiviral activity
against a number of key clinical mutations.
|
 |
|
|
|
|
 |